Is RDNT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RDNT. It does not provide personalized investment advice.

RDNT (RadNet, Inc. Common Stock) Stock Analysis - Financials

RadNet, Inc. Common Stock (RDNT) is a publicly traded Healthcare sector company. As of October 26, 2026, RDNT trades at $67.85 with a market cap of $5.54B and a P/E ratio of -262.35. RDNT moved -0.40% today. Year to date, RDNT is -1.27%; over the trailing twelve months it is -16.02%. Its 52-week range spans $45.00 to $85.84. Analyst consensus is strong buy with an average price target of $91.00. Rallies surfaces RDNT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are RDNT's key financials?

RDNT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RDNT recently traded at $67.85. Market cap is $5.54B. P/E ratio is -262.35. Revenue is $2.27B.

RDNT Key Metrics

Key financial metrics for RDNT
Metric	Value
Price	$67.85
Market Cap	$5.54B
P/E Ratio	-262.35
EPS	$-0.27
Dividend Yield	0.00%
52-Week High	$85.84
52-Week Low	$45.00
Volume	201.40K
Avg Volume	0
Revenue (TTM)	$2.27B
Net Income	$19.27M
Gross Margin	0.00%

RDNT Analyst Consensus

4 analysts cover RDNT: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $91.00.

Common questions about RDNT

What are RDNT's key financials?: RDNT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RDNT recently traded at $67.85. Market cap is $5.54B. P/E ratio is -262.35. Revenue is $2.27B.
Is RDNT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RDNT. It does not provide personalized investment advice.